Movement Disorders (revue) - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Administration, Oral »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Administration, Intravaginal < Administration, Oral < Administration, Sublingual  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 39.
[0-20] [0 - 20][0 - 39][20-38][20-40]
Ident.Authors (with country if any)Title
000101 (1999) R K Pearce [Royaume-Uni]L-dopa and dyskinesias in normal monkeys.
000238 (2000) A J Manson [Royaume-Uni] ; E. Iakovidou ; A J LeesIdazoxan is ineffective for levodopa-induced dyskinesias in Parkinson's disease.
000337 (2000) I. Reuter [Royaume-Uni] ; S. Harder ; M. Engelhardt ; H. BaasThe effect of exercise on pharmacokinetics and pharmacodynamics of levodopa.
000548 (2001) O. Rascol [France] ; I. Arnulf ; H. Peyro-Saint Paul ; C. Brefel-Courbon ; M. Vidailhet ; C. Thalamas ; A M Bonnet ; S. Descombes ; B. Bejjani ; N. Fabre ; J L Montastruc ; Yves Agid [France]Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease.
000721 (2002) Ruth Djaldetti [Israël] ; Rivkah Inzelberg ; Nir Giladi ; Amos D. Korczyn ; Yehudit Peretz-Aharon ; Martin J. Rabey ; Yuval Herishano ; Silvia Honigman ; Sami Badarny ; Eldad MelamedOral solution of levodopa ethylester for treatment of response fluctuations in patients with advanced Parkinson's disease.
000734 (2002) Padraig O'Suilleabhain [États-Unis] ; Richard B. DeweyRandomized trial comparing primidone initiation schedules for treating essential tremor.
000F61 (2004) Lisa Jerome ; Rick Doblin ; Michael MithoeferEcstasy use-Parkinson's disease link tenuous.
001623 (2006) Kaveh M. Koochesfahani [Canada] ; Raúl De La Fuente-Fernández ; Vesna Sossi ; Michael Schulzer ; Lakshmi N. Yatham ; Thomas J. Ruth ; Stephan Blinder ; A Jon StoesslOral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: positron emission tomographic studies.
001705 (2006) Karin Stiasny-Kolster [Allemagne] ; Ralf Kohnen ; Jens Carsten Möller ; Claudia Trenkwalder ; Wolfgang H. OertelValidation of the "L-DOPA test" for diagnosis of restless legs syndrome.
001717 (2006) Angela Deutschl Nder [Allemagne] ; Friedrich Asmus ; Elena Marelli ; Thomas Klopstock ; Thomas Gasser ; Kai BötzelExcellent response to apomorphine in Parkinsonism with optic atrophy unresponsive to oral antiparkinsonian medication.
001793 (2006) J Antonelle Demarcaida [États-Unis] ; Steven R. Schwid ; William B. White ; Karen Blindauer ; Stanley Fahn ; Karl Kieburtz ; Matthew Stern ; Ira ShoulsonEffects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline.
001959 (2007) Jaime Kulisevsky [Espagne] ; Berta Pascual-Sedano ; Manel Barbanoj ; Alexandre Gironell ; Javier Pagonabarraga ; Carmen García-SánchezAcute effects of immediate and controlled-release levodopa on mood in Parkinson's disease: A double-blind study.
001B33 (2007) Regina Katzenschlager [Royaume-Uni] ; Michael J. Jackson ; Sarah Rose ; Kim Stockwell ; Kayhan A. Tayarani-Binazir ; Mohammed Zubair ; Lance A. Smith ; Peter Jenner ; Andrew J. LeesAntiparkinsonian activity of L-propyl-L-leucyl-glycinamide or melanocyte-inhibiting factor in MPTP-treated common marmosets.
001F00 (2008) Birgit Meiler [Allemagne] ; Jürgen Andrich ; Thomas MüllerRapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion.
002196 (2008) Jae Young An ; Joong-Seok Kim ; Yeong-In Kim ; Kwang Soo LeeSuccessful treatment of the Meige syndrome with oral zolpidem monotherapy.
002541 (1991) S T Gancher [États-Unis] ; J G Nutt ; W R WoodwardAbsorption of apomorphine by various routes in parkinsonism.
002975 (2010) Maria Nord [Suède] ; Peter Zsigmond ; Anita Kullman ; Kerstin Arstrand ; Nil DizdarThe effect of peripheral enzyme inhibitors on levodopa concentrations in blood and CSF.
002C11 (1991) R. Kurlan [États-Unis] ; M H Kim ; D M GashOral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: assessment with a new rating scale for monkey parkinsonism.
002D42 (2010) Fabrizio Stocchi [Italie] ; Mario Zappia ; Valentina Dall'Armi ; Jaime Kulisevsky ; Paolo Lamberti ; José Angel ObesoMelevodopa/carbidopa effervescent formulation in the treatment of motor fluctuations in advanced Parkinson's disease.
002E89 (2010) William G. Ondo [États-Unis] ; Lina Shinawi ; Steven MooreComparison of orally dissolving carbidopa/levodopa (Parcopa) to conventional oral carbidopa/levodopa: A single-dose, double-blind, double-dummy, placebo-controlled, crossover trial.
003788 (2012) Raffaella Zannolli [Italie] ; Sabrina Buoni ; Gianni Betti ; Sara Salvucci ; Alessandro Plebani ; Annarosa Soresina ; Maria C. Pietrogrande ; Silvana Martino ; Vincenzo Leuzzi ; Andrea Finocchi ; Roberto Micheli ; Livia Nicoletta Rossi ; Alfredo Brusco ; Filippo Misiani ; Alberto Fois ; Joseph Hayek ; Colleen Kelly ; Luciana ChessaA randomized trial of oral betamethasone to reduce ataxia symptoms in ataxia telangiectasia.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Administration, Oral" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Administration, Oral" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Administration, Oral
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024